Hinge Health (HNGE.US) Director Plans to Sell $11.46 Million in Common Stock via Form 144
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 06 2026
0mins
Should l Buy HNGE?
Source: moomoo
- Stock Sale Announcement: Director Gabriel Mecklenburg plans to sell 250,000 shares of its common stock on March 6.
- Market Value: The total market value of the shares being sold is approximately $11.46 million.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HNGE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HNGE
Wall Street analysts forecast HNGE stock price to rise
14 Analyst Rating
14 Buy
0 Hold
0 Sell
Strong Buy
Current: 36.250
Low
59.00
Averages
64.50
High
72.00
Current: 36.250
Low
59.00
Averages
64.50
High
72.00
About HNGE
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Hinge Health Appoints Tyler Sloat to Board
- New Board Member: Hinge Health has appointed Tyler Sloat, CFO and COO of Freshworks, to its board, bringing nearly three decades of operational leadership experience in high-growth tech companies, which will enhance the company's financial and operational management capabilities.
- Rich Operational Experience: Sloat oversees accounting, finance, IT, and corporate strategy at Freshworks, and previously served as CFO at Zuora, guiding the company from startup to its 2018 IPO, showcasing his leadership in rapid expansion phases.
- Tech-Healthcare Integration: Sloat noted that Hinge Health's platform combines cutting-edge technology with clinical rigor to address significant cost issues in healthcare, and his experience is expected to support the company's further development in healthcare automation.
- Future Outlook: Hinge Health focuses on improving treatment outcomes for musculoskeletal conditions through an AI-powered care model and wearable devices, and Sloat's addition is anticipated to advance the company's mission of enhancing member health outcomes and reducing costs for clients.
See More
Hinge Health (HNGE.US) Director Plans to Sell $11.46 Million in Common Stock via Form 144
- Stock Sale Announcement: Director Gabriel Mecklenburg plans to sell 250,000 shares of its common stock on March 6.
- Market Value: The total market value of the shares being sold is approximately $11.46 million.
See More
Insight Holdings Reduces AppFolio Stake Significantly
- Stake Reduction Impact: Insight Holdings Group reduced its AppFolio position by 108,050 shares in Q4 2025, resulting in a $31.70 million decline in value, indicating a waning confidence in the company's prospects within its overall asset allocation.
- Asset Allocation Shift: AppFolio's weighting in Insight Holdings' 13F assets dropped to 0.78% from 2.6% in the previous quarter, reflecting a broader trend of fund downsizing that may affect market attention towards AppFolio.
- Poor Market Performance: As of February 17, 2026, AppFolio shares were priced at $168.79, down 20.6% over the past year, significantly underperforming the S&P 500 by 34.25 percentage points, highlighting the cooling narratives in both real estate and high-multiple SaaS sectors.
- Business Model Challenges: AppFolio's revenue growth hinges on the number of units managed and the utilization of additional services; investors should monitor whether it can evolve into a financial backbone for clients, thereby increasing revenue per unit and enhancing competitive positioning.
See More
Insight Holdings Fully Exits SentinelOne Position Amid Market Challenges
- Complete Exit: According to a February 17, 2026 SEC filing, Insight Holdings Group, LLC sold its entire position of 8,425,026 shares in SentinelOne during Q4, with an estimated transaction value of $148.36 million, indicating a significant loss of confidence in the company.
- Poor Market Performance: As of February 17, 2026, SentinelOne's stock was priced at $13.40, down 45% over the past year, significantly underperforming the S&P 500 by 57.88 percentage points, reflecting widespread pessimism in the cybersecurity sector.
- Portfolio Reallocation: This transaction reduced Insight Holdings' stake in SentinelOne from over 9% to just 0.7%, suggesting a strategic shift away from the cybersecurity sector, likely due to the company's ongoing losses and the industry's overall poor performance.
- Uncertain Profitability Outlook: Despite a relatively low price-to-sales ratio of less than 5, SentinelOne's continuous net losses and lack of a clear path to profitability have led investors to adopt a cautious stance, with Insight's exit further underscoring the market's lack of confidence in the company's future.
See More
Hinge Health's Patient Movement Data Could Be Its Key Advantage in AI
Rising Healthcare Costs: The cost of healthcare in the U.S. is projected to rise significantly, with estimates indicating an 8.5% increase in medical costs for 2024 and 2025, continuing into 2026, driven by inflationary pressures.
Hinge Health's Business Model: Hinge Health focuses on reducing healthcare costs through its virtual musculoskeletal therapy platform, which allows patients to perform personalized therapy at home, significantly lowering the need for in-person visits and surgeries.
Financial Performance: Hinge Health reported a 46% increase in revenue to $171 million, with adjusted earnings per share rising by 23%. The company anticipates a 25% growth in full-year revenue for 2026, indicating strong market traction.
Investment Potential: Analysts suggest Hinge Health's stock could be an attractive investment opportunity, with a target price indicating a potential upside of around 35%, as the company gains traction among insurers and demonstrates a unique business model in the healthcare sector.
See More
Whale Rock's Investment Moves: New Stakes and Exits
- New Investments: Whale Rock has taken a new stake in Macom Technology Solutions (MTSI) with 783,000 shares valued at $134.1 million, and also added 1 million shares of Sandisk (SNDK) worth $238.2 million, indicating confidence in the semiconductor sector.
- Increased Alphabet Holdings: The fund increased its stake in Alphabet (GOOGL) from 1.17 million shares to 2.10 million shares, raising its value from $657.6 million to $657.6 million, reflecting optimism about the tech giant's future growth.
- Reduction Strategy: Whale Rock reduced its holdings in Celestica (CLS) from 2.99 million shares to 1.88 million shares, decreasing its value from $556.5 million to $556.5 million, indicating a cautious outlook on the company's future performance.
- Exit from Hinge Health: The fund has completely exited its investment in Hinge Health (HNGE), showing a reserved stance on the company's prospects, while also closing its position in Sea Ltd. (SE), possibly to reallocate its investment portfolio.
See More
Hinge Health Appoints Tyler Sloat to Board
- New Board Member: Hinge Health has appointed Tyler Sloat, CFO and COO of Freshworks, to its board, bringing nearly three decades of operational leadership experience in high-growth tech companies, which will enhance the company's financial and operational management capabilities.
- Rich Operational Experience: Sloat oversees accounting, finance, IT, and corporate strategy at Freshworks, and previously served as CFO at Zuora, guiding the company from startup to its 2018 IPO, showcasing his leadership in rapid expansion phases.
- Tech-Healthcare Integration: Sloat noted that Hinge Health's platform combines cutting-edge technology with clinical rigor to address significant cost issues in healthcare, and his experience is expected to support the company's further development in healthcare automation.
- Future Outlook: Hinge Health focuses on improving treatment outcomes for musculoskeletal conditions through an AI-powered care model and wearable devices, and Sloat's addition is anticipated to advance the company's mission of enhancing member health outcomes and reducing costs for clients.
See More
Hinge Health (HNGE.US) Director Plans to Sell $11.46 Million in Common Stock via Form 144
- Stock Sale Announcement: Director Gabriel Mecklenburg plans to sell 250,000 shares of its common stock on March 6.
- Market Value: The total market value of the shares being sold is approximately $11.46 million.
See More
Insight Holdings Reduces AppFolio Stake Significantly
- Stake Reduction Impact: Insight Holdings Group reduced its AppFolio position by 108,050 shares in Q4 2025, resulting in a $31.70 million decline in value, indicating a waning confidence in the company's prospects within its overall asset allocation.
- Asset Allocation Shift: AppFolio's weighting in Insight Holdings' 13F assets dropped to 0.78% from 2.6% in the previous quarter, reflecting a broader trend of fund downsizing that may affect market attention towards AppFolio.
- Poor Market Performance: As of February 17, 2026, AppFolio shares were priced at $168.79, down 20.6% over the past year, significantly underperforming the S&P 500 by 34.25 percentage points, highlighting the cooling narratives in both real estate and high-multiple SaaS sectors.
- Business Model Challenges: AppFolio's revenue growth hinges on the number of units managed and the utilization of additional services; investors should monitor whether it can evolve into a financial backbone for clients, thereby increasing revenue per unit and enhancing competitive positioning.
See More
Insight Holdings Fully Exits SentinelOne Position Amid Market Challenges
- Complete Exit: According to a February 17, 2026 SEC filing, Insight Holdings Group, LLC sold its entire position of 8,425,026 shares in SentinelOne during Q4, with an estimated transaction value of $148.36 million, indicating a significant loss of confidence in the company.
- Poor Market Performance: As of February 17, 2026, SentinelOne's stock was priced at $13.40, down 45% over the past year, significantly underperforming the S&P 500 by 57.88 percentage points, reflecting widespread pessimism in the cybersecurity sector.
- Portfolio Reallocation: This transaction reduced Insight Holdings' stake in SentinelOne from over 9% to just 0.7%, suggesting a strategic shift away from the cybersecurity sector, likely due to the company's ongoing losses and the industry's overall poor performance.
- Uncertain Profitability Outlook: Despite a relatively low price-to-sales ratio of less than 5, SentinelOne's continuous net losses and lack of a clear path to profitability have led investors to adopt a cautious stance, with Insight's exit further underscoring the market's lack of confidence in the company's future.
See More
Hinge Health's Patient Movement Data Could Be Its Key Advantage in AI
Rising Healthcare Costs: The cost of healthcare in the U.S. is projected to rise significantly, with estimates indicating an 8.5% increase in medical costs for 2024 and 2025, continuing into 2026, driven by inflationary pressures.
Hinge Health's Business Model: Hinge Health focuses on reducing healthcare costs through its virtual musculoskeletal therapy platform, which allows patients to perform personalized therapy at home, significantly lowering the need for in-person visits and surgeries.
Financial Performance: Hinge Health reported a 46% increase in revenue to $171 million, with adjusted earnings per share rising by 23%. The company anticipates a 25% growth in full-year revenue for 2026, indicating strong market traction.
Investment Potential: Analysts suggest Hinge Health's stock could be an attractive investment opportunity, with a target price indicating a potential upside of around 35%, as the company gains traction among insurers and demonstrates a unique business model in the healthcare sector.
See More
Whale Rock's Investment Moves: New Stakes and Exits
- New Investments: Whale Rock has taken a new stake in Macom Technology Solutions (MTSI) with 783,000 shares valued at $134.1 million, and also added 1 million shares of Sandisk (SNDK) worth $238.2 million, indicating confidence in the semiconductor sector.
- Increased Alphabet Holdings: The fund increased its stake in Alphabet (GOOGL) from 1.17 million shares to 2.10 million shares, raising its value from $657.6 million to $657.6 million, reflecting optimism about the tech giant's future growth.
- Reduction Strategy: Whale Rock reduced its holdings in Celestica (CLS) from 2.99 million shares to 1.88 million shares, decreasing its value from $556.5 million to $556.5 million, indicating a cautious outlook on the company's future performance.
- Exit from Hinge Health: The fund has completely exited its investment in Hinge Health (HNGE), showing a reserved stance on the company's prospects, while also closing its position in Sea Ltd. (SE), possibly to reallocate its investment portfolio.
See More
